Sino Biological,Inc. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	388.43	322.3	233.35	1,316	2,380	2,872
Trading Asset Securities	2,867	2,900	3,716	3,533	3,422	3,638
Cash & Short-Term Investments	3,255	3,222	3,949	4,849	5,802	6,511
Cash Growth	-17.74%	-18.41%	-18.55%	-16.43%	-10.88%	476.77%
Accounts Receivable	182.32	180.22	151.44	126.33	141.08	154.07
Other Receivables	7.08	19.8	20.18	22.07	15.66	6.18
Receivables	189.4	200.02	171.63	148.4	156.74	160.25
Inventory	80.32	79.22	64.4	52.53	47.49	24.75
Prepaid Expenses	-	-	-	6.63	-	6.35
Other Current Assets	26.23	16.43	22.06	12.65	17.72	16.74
Total Current Assets	3,551	3,518	4,208	5,069	6,024	6,719
Property, Plant & Equipment	895.41	893.1	893.55	900.9	210.96	107.57
Long-Term Investments	401.99	401.13	229.17	215.94	180.24	-
Goodwill	273.89	281.93	278.38	-	-	-
Other Intangible Assets	37.93	40.2	44.79	0.8	1.11	0.92
Long-Term Deferred Tax Assets	104.35	108.05	113.81	104.63	80.28	38.26
Long-Term Deferred Charges	47.81	50.54	59.69	59.73	49	9.31
Other Long-Term Assets	242.93	250.01	227.74	249.64	34.64	15.34
Total Assets	5,556	5,543	6,055	6,601	6,580	6,890
Accounts Payable	19.51	23.72	18.21	19.33	29.23	4.25
Accrued Expenses	44.49	56.66	46.04	54.3	44.09	36.02
Current Portion of Leases	-	22.42	22.47	23.37	19.81	20.45
Current Income Taxes Payable	15.85	5.06	10.3	3.05	6.76	11.94
Current Unearned Revenue	24.27	30.77	35.23	22.74	20.71	13.81
Other Current Liabilities	13.63	14.1	65.26	13.58	4.6	11.89
Total Current Liabilities	133.21	152.73	197.52	136.38	125.2	98.37
Long-Term Leases	31.07	31.1	44.9	61.69	50.65	26.9
Long-Term Unearned Revenue	16.23	10.07	2.54	4.22	5.63	-
Long-Term Deferred Tax Liabilities	36.65	34.11	36.84	31.41	29.64	12.65
Total Liabilities	217.16	228	281.8	233.7	211.11	137.92
Common Stock	121.64	121.64	121.64	129.2	129.2	68
Additional Paid-In Capital	4,354	4,354	4,353	4,796	4,793	4,853
Retained Earnings	871.93	839.79	1,300	1,434	1,432	1,809
Comprehensive Income & Other	-9.56	-0.65	-1.48	7.97	14.51	22.11
Shareholders' Equity	5,338	5,315	5,773	6,367	6,369	6,752
Total Liabilities & Equity	5,556	5,543	6,055	6,601	6,580	6,890
Total Debt	46.53	53.52	67.37	85.06	70.46	47.36
Net Cash (Debt)	3,209	3,169	3,882	4,764	5,732	6,463
Net Cash Growth	-17.68%	-18.38%	-18.51%	-16.89%	-11.32%	472.58%
Net Cash Per Share	26.38	26.05	30.34	36.87	50.32	60.03
Filing Date Shares Outstanding	121.63	121.64	121.64	129.2	129.2	129.2
Total Common Shares Outstanding	121.63	121.64	121.64	129.2	129.2	129.2
Working Capital	3,418	3,365	4,010	4,933	5,899	6,620
Book Value Per Share	43.89	43.69	47.46	49.28	49.30	52.26
Tangible Book Value	5,027	4,993	5,450	6,366	6,368	6,751
Tangible Book Value Per Share	41.33	41.05	44.80	49.27	49.29	52.26
Buildings	-	613.21	637.92	637.92	-	-
Machinery	-	315.79	300.85	268.29	200.86	105.49
Construction In Progress	-	119.32	44.49	8.55	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.